TransMedics (TMDX) Gross Profit Growth (1y) (2019 - 2026)
TransMedics (TMDX) Gross Profit Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 15.59% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 17.10% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 10.88% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 12.38% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 13.54% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 20.50% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 9.82% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 4.20% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 8.95% |
| 10 | TransMedics | 3.18 Bn | 2.71 Bn | 113.20 Mn | 17.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.20% |
| Mar 31, 2026 | 14.66% |
| Dec 31, 2025 | 29.72% |
| Sep 30, 2025 | 39.00% |
| Jun 30, 2025 | 39.46% |
| Mar 31, 2025 | 47.14% |
| Dec 31, 2024 | 50.27% |
| Sep 30, 2024 | 49.64% |
| Jun 30, 2024 | 88.51% |
| Mar 31, 2024 | 108.45% |
| Dec 31, 2023 | 131.48% |
| Sep 30, 2023 | 124.47% |
| Jun 30, 2023 | 156.03% |
| Mar 31, 2023 | 137.66% |
| Dec 31, 2022 | 196.35% |
| Sep 30, 2022 | 380.12% |
| Jun 30, 2022 | 156.75% |
| Mar 31, 2022 | 151.59% |
| Dec 31, 2021 | 44.70% |
| Sep 30, 2021 | -25.11% |